2002
DOI: 10.1182/blood.v100.3.982
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of leukemic cell adhesion, proliferation, and survival by β-catenin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

13
111
1
1

Year Published

2005
2005
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 119 publications
(126 citation statements)
references
References 57 publications
13
111
1
1
Order By: Relevance
“…This is not only time-and reagent-consuming, but the transfection efficiency also varies from experiment to experiment. To solve these problems, a stable clone needs to be established by co-transfecting reporter-and antibiotic-containing plasmids (20,22,23). In the present study, we successfully established stable clone HEK 293-TOP cells that contained a bi-functional reporter plasmid.…”
Section: Discussionmentioning
confidence: 94%
See 2 more Smart Citations
“…This is not only time-and reagent-consuming, but the transfection efficiency also varies from experiment to experiment. To solve these problems, a stable clone needs to be established by co-transfecting reporter-and antibiotic-containing plasmids (20,22,23). In the present study, we successfully established stable clone HEK 293-TOP cells that contained a bi-functional reporter plasmid.…”
Section: Discussionmentioning
confidence: 94%
“…It is well known that the N-terminus of β-catenin (Ser33/Ser37/Thr41) is phosphorylated by GSK-3β and then targeted for ubiquitin-dependent degradation. Although mutation at the N-terminus of β-catenin has been found in some tumors, mutations at these sites have not been found in Jurkat cells (20). NCTD has been reported to inhibit protein phosphatase 2A (PP2A) activity and PP2A has been found to positively control Wnt/β-catenin signaling upon Wnt stimulation (31,32).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The most frequent leukemia in the child is acute lymphoblastic leukemia (ALL). Several papers concerning this subject indicate an activation of the Wnt signaling pathway in ALL [Khan et al, 2007] and an increase in the concentration of β-catenin [Chung et al, 2002]. Other articles showed inhibition of the Wnt signaling pathway as "an attractive target for the use of more specific therapies…" [Román-Gómez, 2007].…”
Section: Discussionmentioning
confidence: 99%
“…Wnt/b-catenin has previously been implicated in the development of human leukaemia: McWhirter et al (1999) showed that the E2a-Pbx fusion protein found in precursor B-acute lymphoblastic leukaemia (ALL) activates the expression of Wnt-16 resulting in a potential autocrine signalling loop. Chung et al (2002) showed that b-catenin protein was expressed in leukaemia cell lines and primary cells to varying levels. Inhibition of the Wnt/b-catenin pathway in Jurkat T-lymphoblastic cells impaired proliferation and increased susceptibility to apoptosis in response to One of the defining features of AML is impaired differentiation of the malignant cells to mature granulocytes and monocytes.…”
Section: Cd34+ Patient Number --------------Aml Cases--------------mentioning
confidence: 99%